- ASCO® 2024
- Yale Cancer Answers
- ASH CME Series
- Smilow Shares with Primary Care
- Grand Rounds
- Head and Neck
- Gynecologic
- Benign Hematology
- Breast
- GI
- Lung
- GU
- Hematologic Oncology
- Brain
- Cancer Screening
- DEI (Diversity, Equity and Inclusion)
- 2021 ASH Highlights
- General Events
- Events
Playback speed
10 seconds
Yale Cancer Center Updates on B-Cell Lymphomas: Exploring MCL, DLBCL, FL, and CLL/SLL
By
Yale Cancer Center
FEATURING
Shalin Kothari
By
Yale Cancer Center
FEATURING
Shalin Kothari
131 views
May 13, 2024
Chapters
Highlighting Phase II BOVen Trial for TP53 Mutant MCL
00:00
Exploring SYMPATICO & BRUIN Trials in Relapsed MCL
03:24
Assessing Bispecific Antibodies for Aggressive B-cell Lymphomas
07:06
Analyzing Treatment Intensity & Loncastuximab Effectiveness in DLBCL
11:37
Unveiling Mosunetuzumab & Bispecific Approaches in Follicular Lymphoma
14:33
Delving Into FLAIR Trial & Sonrotoclax Combo for Treatment-Naive CLL
19:32
Comparing Zanubrutinib vs. Ibrutinib in ALPINE Study for R/R CLL
22:21
Summarizing MCL Updates: Promising Therapies & Treatment Strategies
24:05
Reviewing BTK/BCL2 Combinations & Bispecific Benefits for Lymphomas
25:25
Comments 0
Login to view comments.
Click here to Login
ASH CME Series